Treatment With Erythropoietin and Cognition During Hypoglycaemia
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The purpose of the trial is to determine if erythropoietin (EPO) can enhance cognitive
function during hypoglycaemia in patients with type 1 diabetes.
Patients with type 1 diabetes will receive one injection of EPO. Hypoglycaemia will be
induced 6 days after. Before (1 hour), during and after (1 hour) hypoglycaemia, the cognitive
function will be measured.
Phase:
N/A
Details
Lead Sponsor:
Hillerod Hospital, Denmark
Collaborators:
Aarhus University Hospital Erasmus Medical Center Maastricht University Medical Center Rigshospitalet, Denmark Steno Diabetes Center Steno Diabetes Center Copenhagen